Results 231 to 240 of about 36,696 (303)

Exploring the Therapeutic Potential of Antidiabetic Drugs in Cardiac Arrhythmia Management: A Drug Target Mendelian Randomization Study. [PDF]

J Arrhythm
Song ZQ, Zhou ZB, Wang BX, Wu SK, Sun YH, Chen YH, Feng SY, Sun RF.   +7 more
europepmc   +1 more source

Phenotypic heterogeneity and polygenic risk scores in a family of maturity-onset diabetes of the young. [PDF]

JCEM Case Rep
Chatchomchuan W, Thewjitcharoen Y, Nakasatien S, Himathongkam T, Lim CKP, Chan JCN.   +5 more
europepmc   +1 more source

SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study. [PDF]

J R Soc Med
Cheng WY, Yen FS, Hung YM, Wei JC, Lin HJ, Huang YH, Hsu CC, Hwu CM.   +7 more
europepmc   +1 more source

Comparative effectiveness of antidiabetic therapies on hepatic decompensation in patients with type 2 diabetes: A target trial emulation. [PDF]

JHEP Rep
Choi J, Verma A, Nguyen VH, Przybyszewski E, Song J, Carroll A, Michta M, Almazan E, Simon TG, Chung RT.   +9 more
europepmc   +1 more source

Medication Deprescribing Practices Among Lifestyle Medicine Providers: A Cross-Sectional Survey. [PDF]

Am J Lifestyle Med
Macfield J, Staffier KL, Kelly J, Moghe R, Karlsen MC.   +4 more
europepmc   +1 more source

Quo Vadis, Sulfonylureas?

Gastroenterology, 1957
openaire   +2 more sources

Spectroscopic studies on binding of 1-phenyl-3-(coumarin-6-yl)sulfonylurea to bovine serum albumin

, 2008
Xiaohui Liu, Pin-xian Xi, Fengjuan Chen, Zhi-Hong Xu, Zhengzhi Zeng   +4 more
openalex   +2 more sources

Patterns and Clinical Outcomes of Sitagliptin/Metformin Extended-Release in Internal Medicine: A Real-World Multicenter Italian Study. [PDF]

J Clin Med
De Luca M, Arcopinto M, Bosco G, Cicco S, Di Giacomo Barbagallo F, Giacinti C, Marozzi MS, Masala MS, Pinna M, Pucci G, Salzano A, Scicali R, Marra AM, Cittadini A, CLUB Study-Group.   +14 more
europepmc   +1 more source

Exploitation of sulfonylurea resistance marker and non-homologous end joining mutants for functional analysis in Zymoseptoria tritici

, 2015
Yaadwinder Sidhu, Timothy C. Cairns, Yogesh Chaudhari, Jane Usher, Nicholas J. Talbot, David J. Studholme, Michael Csukai, Ken Haynes   +7 more
openalex   +1 more source

Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. [PDF]

Diabetes Care
Park CM, Thanapluetiwong S, Chen X, Oh G, Ko D, Kim DH.   +5 more
europepmc   +1 more source